Journal
JOURNAL OF PERSONALIZED MEDICINE
Volume 11, Issue 12, Pages -Publisher
MDPI
DOI: 10.3390/jpm11121279
Keywords
women; psychosis; schizophrenia; gender differences; personalized treatment
Ask authors/readers for more resources
Gender differences play a crucial role in early detection and personalized treatment of psychosis. Women with psychosis tend to have better overall functioning at symptom onset but are more likely to experience mood symptoms and potential side effects of medication.
Early detection and prompt treatment of psychosis is of the utmost importance. The great variability in clinical onset, illness course, and response to pharmacological and psychosocial treatment is in great part gender-related. Our aim has been to review narratively the literature focusing on gender related differences in the psychoses, i.e., schizophrenia spectrum disorders. We searched the PubMed/Medline, Scopus, Embase, and ScienceDirect databases on 31 July 2021, focusing on recent research regarding sex differences in early psychosis. Although women, compared to men, tend to have better overall functioning at psychotic symptom onset, they often present with more mood symptoms, may undergo misdiagnosis and delay in treatment and are at a higher risk for antipsychotic drug-induced metabolic and endocrine-induced side effects. Furthermore, women with schizophrenia spectrum disorders have more than double the odds of having physical comorbidities than men. Tailored treatment plans delivered by healthcare services should consider gender differences in patients with a diagnosis of psychosis, with a particular attention to early phases of disease in the context of the staging model of psychosis onset.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available